181 related articles for article (PubMed ID: 35704074)
21. Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease.
Butman JA; Kim HJ; Baggenstos M; Ammerman JM; Dambrosia J; Patsalides A; Patronas NJ; Oldfield EH; Lonser RR
JAMA; 2007 Jul; 298(1):41-8. PubMed ID: 17609489
[TBL] [Abstract][Full Text] [Related]
22. von Hippel-Lindau disease: deafness due to a non-MRI-visible endolymphatic sac tumor despite targeted screening.
Binderup ML; Gimsing S; Kosteljanetz M; Thomsen C; Bisgaard ML
Int J Audiol; 2013 Nov; 52(11):771-5. PubMed ID: 24003980
[TBL] [Abstract][Full Text] [Related]
23. [Tumour staged surgery of endolymphatic sac tumors (ELST)].
Schipper J; Maier W; Rosahl S; Berlis A; Laszig R
Laryngorhinootologie; 2004 Aug; 83(8):493-500. PubMed ID: 15316888
[TBL] [Abstract][Full Text] [Related]
24. Mutation of von Hippel-Lindau tumor suppressor gene in a sporadic endolymphatic sac tumor.
Hamazaki S; Yoshida M; Yao M; Nagashima Y; Taguchi K; Nakashima H; Okada S
Hum Pathol; 2001 Nov; 32(11):1272-6. PubMed ID: 11727270
[TBL] [Abstract][Full Text] [Related]
25. A histopathological connection between a fatal endolymphatic sac tumour and von Hippel-Lindau disease from 1960.
Bellairs JA; Gluth MB
J Laryngol Otol; 2018 Jan; 132(1):75-78. PubMed ID: 28874214
[TBL] [Abstract][Full Text] [Related]
26. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients.
Thompson LDR; Magliocca KR; Andreasen S; Kiss K; Rooper L; Stelow E; Wenig BM; Bishop JA
Head Neck Pathol; 2019 Sep; 13(3):355-363. PubMed ID: 30291511
[TBL] [Abstract][Full Text] [Related]
27. Tumors of the endolymphatic sac in von Hippel-Lindau disease.
Lonser RR; Kim HJ; Butman JA; Vortmeyer AO; Choo DI; Oldfield EH
N Engl J Med; 2004 Jun; 350(24):2481-6. PubMed ID: 15190140
[No Abstract] [Full Text] [Related]
28. Systematic Review of Endolymphatic Sac Tumor Treatment and Outcomes.
Tang JD; Grady AJ; Nickel CJ; Ryan LE; Malone A; Canvasser L; Boyev KP
Otolaryngol Head Neck Surg; 2023 Mar; 168(3):282-290. PubMed ID: 35763364
[TBL] [Abstract][Full Text] [Related]
29. Endolymphatic sac tumors.
Wick CC; Manzoor NF; Semaan MT; Megerian CA
Otolaryngol Clin North Am; 2015 Apr; 48(2):317-30. PubMed ID: 25650230
[TBL] [Abstract][Full Text] [Related]
30. Clinicoradiologic characteristics of endolymphatic sac tumors.
Le H; Zhang H; Tao W; Lin L; Li J; Ma L; Hong G; Lou X
Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2705-2714. PubMed ID: 31197530
[TBL] [Abstract][Full Text] [Related]
31. Isolate vertigo crisis revealing an endolymphatic sac tumor.
Codreanu C; Tran Ba Huy P
Rom J Morphol Embryol; 2010; 51(2):387-9. PubMed ID: 20495761
[TBL] [Abstract][Full Text] [Related]
32. Endolymphatic sac tumour - a rare complication associated with von Hippel-Lindau disease.
Wozniaková M; Židlík V; Škarda J
Cesk Patol; 2023; 59(1):32-35. PubMed ID: 37072278
[TBL] [Abstract][Full Text] [Related]
33. Current Treatment of Endolymphatic Sac Tumor of the Temporal Bone.
Mendenhall WM; Suárez C; Skálová A; Strojan P; Triantafyllou A; Devaney KO; Williams MD; Rinaldo A; Ferlito A
Adv Ther; 2018 Jul; 35(7):887-898. PubMed ID: 29923043
[TBL] [Abstract][Full Text] [Related]
34. The vestibular aqueduct: site of origin of endolymphatic sac tumors.
Lonser RR; Baggenstos M; Kim HJ; Butman JA; Vortmeyer AO
J Neurosurg; 2008 Apr; 108(4):751-6. PubMed ID: 18377255
[TBL] [Abstract][Full Text] [Related]
35. Surgical Management of Endolymphatic Sac Tumor: A Systematic Review and Meta-Analysis.
Gioacchini FM; Chiarella G; Kaleci S; Iannella G; Viola P; Pisani D; Scarpa A; Tulli M; Re M
J Int Adv Otol; 2023 Jun; 19(3):248-254. PubMed ID: 37272644
[TBL] [Abstract][Full Text] [Related]
36. Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with analysis of von Hippel-Lindau gene and review.
Rao Q; Zhou J; Wang JD; Jin XZ; Ma HH; Lu ZF; Zhou XJ
Ann Diagn Pathol; 2010 Oct; 14(5):361-4. PubMed ID: 20850701
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological features of low-grade malignant endolymphatic sac tumors.
Wang HQ; Jie L; Shi HY
Pathol Res Pract; 2018 Mar; 214(3):431-435. PubMed ID: 29482989
[TBL] [Abstract][Full Text] [Related]
38. Hearing preservation surgery for small endolymphatic sac tumors in patients with von Hippel-Lindau syndrome.
Megerian CA; Haynes DS; Poe DS; Choo DI; Keriakas TJ; Glasscock ME
Otol Neurotol; 2002 May; 23(3):378-87. PubMed ID: 11981399
[TBL] [Abstract][Full Text] [Related]
39. Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls.
Jester R; Znoyko I; Garnovskaya M; Rozier JN; Kegl R; Patel S; Tran T; Abedalthagafi M; Horbinski CM; Richardson M; Wolff DJ; Lapadat R; Moore W; Rodriguez FJ; Mull J; Olar A
Acta Neuropathol Commun; 2018 Oct; 6(1):107. PubMed ID: 30340515
[TBL] [Abstract][Full Text] [Related]
40. Endolymphatic sac tumour in von Hippel-Lindau disease: management strategies.
Zanoletti E; Girasoli L; Borsetto D; Opocher G; Mazzoni A; Martini A
Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):423-429. PubMed ID: 29165437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
